172 related articles for article (PubMed ID: 26523208)
1. Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway.
Lee MH; Kachroo P; Pagano PC; Yanagawa J; Wang G; Walser TC; Krysan K; Sharma S; John MS; Dubinett SM; Lee JM
J Cancer Sci Ther; 2014 Nov; 6(11):468-477. PubMed ID: 26523208
[TBL] [Abstract][Full Text] [Related]
2. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer.
Kachroo P; Lee MH; Zhang L; Baratelli F; Lee G; Srivastava MK; Wang G; Walser TC; Krysan K; Sharma S; Dubinett SM; Lee JM
J Exp Clin Cancer Res; 2013 Nov; 32(1):97. PubMed ID: 24274066
[TBL] [Abstract][Full Text] [Related]
3. Apricoxib upregulates 15-PGDH and PGT in tobacco-related epithelial malignancies.
St John MA; Wang G; Luo J; Dohadwala M; Hu D; Lin Y; Dennis M; Lee JM; Elashoff D; Lawhon T; Zaknoen SL; Burrows FJ; Dubinett SM
Br J Cancer; 2012 Aug; 107(4):707-12. PubMed ID: 22828609
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib.
Kirane A; Toombs JE; Larsen JE; Ostapoff KT; Meshaw KR; Zaknoen S; Brekken RA; Burrows FJ
Carcinogenesis; 2012 Sep; 33(9):1639-46. PubMed ID: 22678114
[TBL] [Abstract][Full Text] [Related]
5. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
6. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
7. IL-27 inhibits the TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells.
Dong Z; Tai W; Lei W; Wang Y; Li Z; Zhang T
BMC Cell Biol; 2016 Mar; 17():7. PubMed ID: 26932661
[TBL] [Abstract][Full Text] [Related]
8. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
Kirane A; Toombs JE; Ostapoff K; Carbon JG; Zaknoen S; Braunfeld J; Schwarz RE; Burrows FJ; Brekken RA
Clin Cancer Res; 2012 Sep; 18(18):5031-42. PubMed ID: 22829202
[TBL] [Abstract][Full Text] [Related]
9. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
Gao S; Hu J; Wu X; Liang Z
Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
[TBL] [Abstract][Full Text] [Related]
10. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
11. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
13. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
[TBL] [Abstract][Full Text] [Related]
14. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
15. Effect of Baricitinib on the epithelial-mesenchymal transition of alveolar epithelial cells induced by IL-6.
Liu Y; Hu M; Fan G; Xing N; Zhang R
Int Immunopharmacol; 2022 Sep; 110():109044. PubMed ID: 35850052
[TBL] [Abstract][Full Text] [Related]
16. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway.
Kong G; Jiang Y; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Cheng G
Oncol Rep; 2017 Nov; 38(5):2647-2656. PubMed ID: 29048621
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway.
Shen M; Xu Z; Xu W; Jiang K; Zhang F; Ding Q; Xu Z; Chen Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):149. PubMed ID: 30961670
[TBL] [Abstract][Full Text] [Related]
18. [The effects and mechanisms of interleukin-22 and interferon-γ on epithelial-mesenchymal transition of pleural mesothelial cells].
Ye Z; Li M; Mei Z; Zhen G; Zhang P
Zhonghua Jie He He Hu Xi Za Zhi; 2015 Jul; 38(7):501-6. PubMed ID: 26703015
[TBL] [Abstract][Full Text] [Related]
19. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
20. Wogonin suppresses human alveolar adenocarcinoma cell A549 migration in inflammatory microenvironment by modulating the IL-6/STAT3 signaling pathway.
Zhao Y; Yao J; Wu XP; Zhao L; Zhou YX; Zhang Y; You QD; Guo QL; Lu N
Mol Carcinog; 2015 Jun; 54 Suppl 1():E81-93. PubMed ID: 24976450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
